Related Experiment Video
Updated: Jan 27, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue
Henry G Smith1,2, David Mansfield1, Victoria Roulstone1
1Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.
Purpose:
The prevention and treatment of metastatic sarcoma are areas of significant unmet need. Immune checkpoint inhibitor monotherapy has shown little activity in sarcoma and there is great interest in identifying novel treatment combinations that may augment responses. In vitro and in vivo, we investigated the potential for an oncolytic vaccinia virus (GLV-1h68) delivered using isolated limb perfusion (ILP) to promote antitumor immune responses and augment response to PD-1 blockade in sarcoma.Experimental Design: In an established animal model of extremity sarcoma, we evaluated the potential of locoregional delivery of a vaccinia virus (GLV-1h68) alongside biochemotherapy (melphalan/TNFα) in ILP. Complementary in vitro assays for markers of immunogenic cell death were performed in sarcoma cell lines.
Results:
PD-1 monotherapy had minimal efficacy in vivo, mimicking the clinical scenario. Pretreatment with GLV-1h68 delivered by ILP (viral ILP) significantly improved responses. Furthermore, when performed prior to surgery and radiotherapy, viral ILP and PD-1 blockade prevented both local and distant relapse, curing a previously treatment-refractory model. Enhanced therapy was associated with marked modulation of the tumor microenvironment, with an increase in the number and penetrance of intratumoral CD8+ T cells and expansion and activation of dendritic cells. GLV-1h68 was capable of inducing markers of immunogenic cell death in human sarcoma cell lines.
Conclusions:
Viral ILP augments the response to PD-1 blockade, transforming this locoregional therapy into a potentially effective systemic treatment for sarcoma and warrants translational evaluation.
Insights
Combining oncolytic vaccinia virus (GLV-1h68) via isolated limb perfusion with PD-1 blockade shows promise for treating sarcoma. This novel approach enhances antitumor immunity and prevents relapse in preclinical models.
Area of Science:
- Oncology
- Immunotherapy
- Virology
Background:
- Metastatic sarcoma presents a significant unmet clinical need.
- Immune checkpoint inhibitor monotherapy demonstrates limited efficacy in sarcoma.
- Novel combination therapies are required to improve treatment outcomes.
Purpose of the Study:
- To investigate the potential of oncolytic vaccinia virus (GLV-1h68) delivered via isolated limb perfusion (ILP) to enhance antitumor immune responses.
- To evaluate the combination of viral ILP and PD-1 blockade for sarcoma treatment.
- To assess the in vitro and in vivo efficacy of this combined approach.
Main Methods:
- Utilized an established animal model of extremity sarcoma.
- Administered locoregional delivery of GLV-1h68 via ILP, combined with biochemotherapy (melphalan/TNFα).
- Performed in vitro assays to detect markers of immunogenic cell death in sarcoma cell lines.
Main Results:
- PD-1 blockade monotherapy showed minimal efficacy, consistent with clinical observations.
- Pretreatment with viral ILP significantly improved treatment responses.
- The combination therapy prevented local and distant relapse, leading to cure in a refractory model.
- Observed increased intratumoral CD8+ T cells and enhanced dendritic cell activation, indicating immune modulation.
- GLV-1h68 induced immunogenic cell death markers in human sarcoma cell lines.
Conclusions:
- Viral ILP combined with PD-1 blockade augments antitumor immune responses.
- This combination transforms a locoregional therapy into a potentially effective systemic treatment for sarcoma.
- The findings warrant further translational evaluation for clinical application.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Neuromuscular Junction And Blockade
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
What are Viruses?
Cancer Prevention
Some...
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...

